Key result
Long-term digoxin therapy yields myocardial concentrations ~65-fold higher than plasma levels.
Cross-Sectional (n=8)
No
Demonstrates wide inter-individual variation in the myocardial-to-plasma digoxin ratio (39:1 to 155:1) in patients on long-term therapy, showing that plasma levels do not simply reflect total myocardial digoxin stores and that only a tiny fraction of body digoxin resides in plasma.
Answers are grounded in this paper and cite their sources.
Plasma digoxin levels may poorly reflect myocardial stores amid wide variability; leaves open need for refined monitoring and tissue PK studies.
The digoxin content was measured in samples of left ventricular papillary muscle, skeletal muscle, and plasma obtained during mitral valve replacement from eight patients on maintenance treatment with the drug. The content in papillary muscle ranged from 15.5 to 132 ng/g (mean 77.7) and in skeletal muscle from 7.5 to 23 ng/g (mean 11.3). The ratio of myocardial digoxin concentration to plasma concentration varied between patients from 39:1 to 155:1. No simple relationship exists between plasma levels of digoxin and its concentration in the heart muscle, but total myocardial concentration may not accurately reflect therapeutic activity.
No takes yet. Share an insight, caveat, or question.
Coltart et al. (1972) conducted a cross-sectional in Valvular heart disease requiring mitral valve replacement on long-term digoxin therapy (n=8). Long-term maintenance digoxin therapy was evaluated on Digoxin concentrations and ratios in left ventricular papillary muscle, skeletal muscle, and plasma. Long-term digoxin therapy resulted in mean concentrations of 77.7 ng/g in papillary muscle, 11.3 ng/g in skeletal muscle, and 1.2 ng/ml in plasma, with myocardial-to-plasma ratios of 39:1 to 155:1.
Synapse has enriched 10 related papers. Consider them for comparative context: